Target intelligence / Profile preview

Mitochondrial ribosomal protein S14 (MRPS14)

Target
MRPS14
Molecular classification
Ribosomal protein, Structural protein, Mitochondrial ribosomal subunit protein, Other (not a receptor, enzyme, transporter, transcription factor, etc.)
01

Overview

Mitochondrial ribosomal protein S14 (MRPS14) is a nuclear-encoded protein that is part of the 28S small subunit of the mitochondrial ribosome. It is essential for mitochondrial protein synthesis by facilitating mRNA recruitment and translation elongation within the mitochondria. Diseases caused by pathogenic variants in MRPS14 include combined oxidative phosphorylation deficiency, hypertrophic cardiomyopathy, and lactic acidosis. Although mitoribosomal proteins differ substantially from their prokaryotic homologs, MRPS14 belongs to the ribosomal protein S14P family and performs a structural and functional role within the mitochondrial ribosome. MRPS14 is not a classical drug target, but the mitoribosome as a whole has been implicated as a target in the context of certain antibiotics and investigational cancer therapies. Disruption of MRPS14 impairs energy production and mitochondrial homeostasis, leading to severe clinical manifestations.

Other names
Small ribosomal subunit protein uS14mMRP-S14S14mtHSMRPS1428S ribosomal protein S14, mitochondrialCOXPD38DJ262D12.2mitochondrial small ribosomal subunit protein uS14mmitochondrial 28S ribosomal protein S14
02

Biological functions

Mitochondrial translationStructural constituent of ribosomeRNA bindingProtein synthesis in mitochondria
03

Disease associations

Mitochondrial diseaseCombined oxidative phosphorylation deficiency 38 (COXPD38)Perinatal hypertrophic cardiomyopathyGrowth retardationLactic acidosis
04

Safety considerations

Impaired mitochondrial translation can result in severe clinical phenotypes, including cardiomyopathy, lactic acidosis, and growth retardationUnintended inhibition of mitochondrial ribosomal proteins by some antibiotics can lead to mitochondrial toxicityTherapeutic targeting poses risk for mitochondrial dysfunction in non-target tissues

Beyond the preview

Go deeper on Mitochondrial ribosomal protein S14 (MRPS14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ribosomal protein S14 (MRPS14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call